Correlation between individual inflammation genetic profile and platelet rich plasma efficacy in hair follicle regeneration: A pilot study reveals prognostic value of IL-1α polymorphism

European Review for Medical and Pharmacological Sciences

Volumn 21, Issue 22, 2017, Pages 5247-5257

  Rossano, F ^a   Di Martino, S ^a   Iodice, L ^b   Di Paolo, M ^a   Misso, S ^c   Tomeo, R ^c   Marini, A M ^d   Brugnone, R ^e   Marlino, S ^f   Santorelli, A ^f   Di Francia, R ^g  

^a CETAC Research Center   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c g Moscati Hospital   (Italy)

^d Marini Polidiagnostic Center   (Italy)

^e ID Transfusion srl   (Italy)

^f Health Park Hospital   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Alopecia; Cytokines; IL 1 ; Inflammation genetic profile; Platelet rich plasma; Polymorphisms

Indexed keywords

ADENOSINE; CYSTEINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; IL1A PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HAIR ANALYSIS; HAIR DENSITY; HAIR FOLLICLE; HAIR LOSS; HUMAN; IL 10 GENE; IL 1ALPHA GENE; IL 1BETA GENE; IL 6 GENE; INFLAMMATION; MALE; PILOT STUDY; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; TREATMENT DURATION; TREATMENT RESPONSE; CORRELATION ANALYSIS; CYTOKINE RESPONSE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PROFILE; GENETIC VARIABILITY; HAIR GROWTH; HUMAN CELL; MAJOR CLINICAL STUDY; PROGNOSTIC ASSESSMENT; SEX DIFFERENCE; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAIR; MIDDLE AGED; REGENERATION; SEXUAL CHARACTERISTICS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HAIR; HAIR FOLLICLE; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET-RICH PLASMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REGENERATION; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 85038022744     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481-3488.
2. Brass LF. Thrombin and platelet activation. Chest 2003; 124(3 Suppl): 18S-25S.
3. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99: 1293-1304.
4. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597-607.
5. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009; 23: 177-189.
6. Badimon L, Vilahur G, Padró T. Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol 2009; 62: 1161-1178.
7. Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2281-2285.
8. Jin J, Quinton TM, Zhang J, Rittenhouse SE, Kunapuli SP. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood 2002; 99: 193-198.
9. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and wellbeing. Neuroimmunomodulat 2005; 12: 255-269.
10. Malkowska A, Kasprzak A, Stopa J. Proinflammatory cytokines in pathogenesis of periodontal disease. Pol Merkur Lekarski 2006; 20: 93-98.
11. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 2010; 5: e9016.
12. Yano S, Sone S, Nishioka Y, Mukaida N, Matsushima K, Ogura T. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor. J Leukoc Biol 1995; 57: 303-309.
13. Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010; 6: 232-241.
14. McDevitt MJ, Wang HY, Knobelman C, Newman MG, di Giovine FS, Timms J, Duff GW, Kornman KS. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000; 71: 156-163.
15. Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Lang NP, Seymour GJ. A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol 2001; 28: 1137-1144.
16. Shirodaria S, Smith J, McKay IJ, Kennet CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1a protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000; 79: 1864-1869.
17. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG. Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol 2008; 35: 754-767.
18. Shete AR, Joseph R, Vijayan NN, Srinivas L, Banerjee M. Association of single nucleotide gene polymorphism at interleukin-1beta +3954, -511, and -31 in chronic periodontitis and aggressive periodontitis in Dravidian ethnicity. J Periodontol 2010; 81: 62-69.
19. Liz-Graña M, Gómez-Reino Carnota J. Tumour necrosis factor. Genetics, cell action mechanism and involvement in inflammation. Allergol Immunol Clin 2001; 16: 140-149.
20. Brinkman BM, Kaijzel EL, Huizinga TW, Giphart MJ, Breedveld FC, Verweij CL. Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 1995; 96: 493.
21. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-154.
22. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359-367.
23. Di Francia R, Siesto RS, Valente D, Spartà D, Berretta M. Pharmacogenomics panel test for prevention toxicity in patients who recieve Fluoropirimidine/oxaliplatin-based therapy. Eur Rev Med Pharmacol Sci 2012; 16: 215-298
24. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
25. Fassmann A, Holla LI, Buckova D, Vasku A, Znojil V, Vanek J. Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population. J Periodontal Res 2003; 38: 394-399.
26. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol 1998; 3: 327-338.
27. Endo M, Tai H, Tabeta K, Kobayashi T, Yamazaki K, Yoshie H. Analysis of single nucleotide polymorphisms in the 5′-flanking region of tumor necro sis factor-alpha gene in Japanese patients with early-onset periodontitis. J Periodontol 2001; 72: 1554-1559.
28. Perez C, Gonzalez FE, Pavez V, Araya AV, Aguirre A, Cruzat A, Contreras-Levicoy J, Dotte A, Aravena O, Salazar L, Catalan D, Cuenca J, Ferreira A, Schiattino I, Aguillon JC. The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus. Eur Cytokine Netw 2004; 15: 364-370.
29. Trevilatto PC, Tramontina VA, Machado MA, Goncalves RB, Sallum AW, Line SR. Clinical, genetic and microbiological findings in a Brazilian family with aggressive periodontitis. J Clin Periodontol 2002; 29: 233-239.
30. Craandijk J, van Krugten MV, Verweij CL, van der Velden U, Loos BG. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J Clin Periodontol 2002; 29: 28-34.
31. Soga Y, Nishimura F, Ohyama H, Maeda H, Takashiba S, Murayama Y. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003; 30: 524-531.
32. Holla LI, Fassmann A, Stejskalova A, Znojil V, Vanek J, Vacha J. Analysis of the interleukin-6 gene promoter polymorphisms in Czech patients with chronic periodontitis. J Periodontol 2004; 75: 30-36.
33. Nibali L, D'Aiuto F, Donos N, Griffiths GS, Parkar M, Tonetti MS, Humphries SE, Brett PM. Association between periodontitis and common variants in the promoter of the interleukin-6 gene. Cytokine 2009, 45: 50-54.
34. Komatsu Y, Tai H, Galicia JC, Shimada Y, Endo M, Akazawa K, Yamazaki K, Yoshie H. Interleukin-6 (IL- 6)-373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level. Tissue Antigens 2005; 65: 110-114.
35. Trevilatto PC, Scarel-Caminaga RM, de Brito RB, de Souza AP, Line SR. Polymorphism at position -174 of IL-6 gene is associated with susceptibility to hronic periodontitis in a Caucasian Brazilian population. J Clin Periodontol 2003; 30: 438-442.
36. D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine 2004; 28: 29-34.
37. D'Aiuto F, Ready D, Parkar M, Tonetti MS. Relative contribution of patient-, tooth-, and site-associated variability on the clinical outcomes of subgingival debridement. I. Probing depths. J Periodontol 2005; 76: 398-405.
38. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102: 1369-1376.
39. Cesar-Neto JB, Duarte PM, de Oliveira MC, Casati MZ, Tambeli CH, Parada CA, Sallum EA, Nociti FH. Smoking modulates interferon-gamma expression in the gingival tissue of patients with chronic periodontitis. Eur J Oral Sci 2006; 114: 403-408.
40. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFNgamma production. Hum Immunol 2000; 61: 863-866.
41. Babel N, Cherepnev G, Babel D, Tropmann A, Hammer M, Volk HD. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, nterleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with hronic periodontitis. J Periodontol 2006, 77: 1978-1983.
42. Sutherland GR, Baker E, Callen DF, Hyland VJ, Wong G, Clark S. Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet 1988; 79: 335-337.
43. McFarlane CG, Meikle MC. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. J Periodontal Res 1991; 26: 402-408.
44. Mout R, Willemze R, Landegent JE. Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 1991; 19: 3763.
45. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148: 3618-3623.
46. Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Camargo LE, Line SR. Interleukin 10 gene promoter polymorphisms are associated with chronic periodontitis. J Clin Periodontol 2004; 31: 443-448.
47. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-128.
48. Berglundh T, Donati M, Hahn-Zoric M, Hanson LA, Padyukov L. Association of the -1087 IL 10 gene polymorphism with severe chronic periodontitis in Swedish Caucasians. J Clin Periodontol 2003; 30: 249-254.
49. Lee EH, Kang JS, Kang DS, Han CS, Oh SH, Cho SB. Facilitated scalp is measuring using phototrichogram with a headband and tapeline. Dermatol Surg 2011; 37: 1150-1152.
50. Mazzocca AD, McCarthy MBR, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, Arciero RA, Beitzel K. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012; 94: 308-316.
51. Tang TY, Zhou XX, Huang H, Huang QD. Relationship between IL-1β polymorphisms and obstructive sleep apnea syndrome. Eur Rev Med Pharmacol Sci 2017; 21: 3120-3128.
52. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am 2012; 94: e143.
53. Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2008; 2: 472-481.
54. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37: 2259-2272.
55. Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN. Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sportsmed 2011; 39: 42-51.
56. Berretta M, Di Francia R, Tirelli U. Editorial - The new oncologic challenges in the 3RD millennium. WCRJ 2014; 1: e133.
57. Rinaldi S, Bussa M, Mascaro A. Update on the treatment of androgenetic alopecia. Eur Rev Med Pharmacol Sci 2016; 20: 54-58.
58. Cillo M, Di Paolo M, Pugliese S, Troisi A, Crescente G, Marotta G. Costs and quality of genomics tests in the oncology field. WCRJ 2016; 3: e801.